Thoraxjnl-2017-210593.Full.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Thoraxjnl-2017-210593.Full.Pdf Chronic obstructive pulmonary disease ORIGINAL ARTICLE Thorax: first published as 10.1136/thoraxjnl-2017-210593 on 10 July 2018. Downloaded from NOTCH3 contributes to rhinovirus-induced goblet cell hyperplasia in COPD airway epithelial cells Yaxun Jing,1 Joao Antonio Gimenes,2 Rahul Mishra,1 Duc Pham,1 Adam T Comstock,1 Daohai Yu,3 Umadevi Sajjan1,2,4 ► Additional material is ABSTRact published online only. To view Rationale Goblet cell hyperplasia (GCH) is one of Key messages please visit the journal online (http:// dx. doi. org/ 10. 1136/ the cardinal features of chronic obstructive pulmonary thoraxjnl- 2017- 210593). disease (COPD) and contributes to airways obstruction. What is the key question? Rhinovirus (RV), which causes acute exacerbations in ► Does rhinovirus infection induce goblet cell 1Department of Pediatrics patients with COPD, also causes prolonged airways hyperplasia in chronic obstructive pulmonary and Communicable Diseases, obstruction. Previously, we showed that RV enhances disease (COPD) and what is the underlying University of Michigan, Ann mechanism? Arbor, Michigan, USA mucin gene expression and increases goblet cell number 2 Department of Thoracic Surgery in a COPD mouse model. This study examines whether What is the bottom line? and Medicine, Temple University, RV causes sustained GCH in relevant models of COPD. ► Rhinovirus, which is associated with acute Philadelphia, Pennsylvania, USA Methods Mucociliary-differentiated COPD and normal 3Department of Clinical exacerbations in COPD, can promote goblet airway epithelial cell cultures and mice with normal Sciences, Temple University, cell hyperplasia, one of the features of airway or COPD phenotype were infected with RV or sham Philadelphia, Pennsylvania, USA epithelial remodelling in COPD. 4Department of Physiology, and examined for GCH by immunofluorescence and/ Temple University, Philadelphia, or mucin gene expression. In some experiments, RV- Why read on? Pennsylvania, USA infected COPD cells and mice with COPD phenotype ► We demonstrated that rhinovirus induces were treated with γ-secretase inhibitor or interleukin-13 goblet cell hyperplasia in in vitro and in Correspondence to Professor Umadevi Sajjan, neutralising antibody and assessed for GCH. To vivo models of COPD through NOTCH Departments of Physiology, and determine the contribution of NOTCH1/3 in RV-induced signalling independent of well-characterised Thoracic Medicine and Surgery, GCH, COPD cells transduced with NOTCH1/3 shRNA interleukin-13 pathway. Center for Inflammation, were used. Translational and Clinical Lung Results RV-infected COPD, but not normal cell cultures, Research, Lewis Katz Medical School, Temple University, showed sustained GCH and increased mucin genes and this may be a result of abnormal responses to Philadelphia PA 19140, USA; expression. Microarray analysis indicated increased infections or other noxious agents. http://thorax.bmj.com/ uma. sajjan@ temple. edu expression of NOTCH1, NOTCH3 and HEY1 only in RV- Rhinovirus (RV), which causes self-limiting upper infected COPD cells. Blocking NOTCH3, but not NOTCH1, airway infections in healthy subjects, is associated Received 31 May 2017 with acute exacerbations in COPD. Patients with Revised 15 May 2018 attenuated RV-induced GCH in vitro. Inhibition of NOTCH Accepted 11 June 2018 signalling by γ-secretase inhibitor, but not neutralising mild COPD experimentally infected with RV show antibody to IL-13, abrogated RV-induced GCH and mucin more severe and prolonged lower airway symptoms gene expression. including airflow obstruction.1 We demonstrated Conclusions RV induces sustained GCH via NOTCH3 that RV enhances mucin gene expression and particularly in COPD cells or mice with COPD phenotype. GCH within 4 days postinfection in two different on September 23, 2021 by guest. Protected copyright. This may be one of the mechanisms that may contribute models of COPD.2 3 Therefore, it is plausible that to RV-induced prolonged airways obstruction in COPD. RV may induce or perpetuate GCH in patients with COPD, thus causing excessive mucus production and airways obstruction. However, mechanisms by which RV induces sustained GCH in COPD are not INTRODUCTION well understood. Mucus overlaying the airway epithelium traps the Most studies conducted on respiratory virus-in- inhaled pathogens and other noxious agents and duced GCH have focused on models of allergic the coordinated beating of cilia clear mucus along asthma or virus infection model that induces with the trapped inhaled agents. Thus, both cilia type II responses. Although viral infection causes and mucus contribute to primary defence mech- airway obstruction in both patients with asthma © Author(s) (or their anism of airway epithelium. However, in chronic and COPD, the underlying mechanisms may differ employer(s)) 2018. No inflammatory airway disease including chronic because of different type of responses. In allergic commercial re-use. See rights and permissions. Published obstructive pulmonary disease (COPD), there is asthma, viral infection predominantly induces type by BMJ. excessive mucus production, which may subse- 2 cytokines, such as interleukin (IL)-13, IL-4 and quently cause airways obstruction and disease IL-5.4 IL-13 has been shown to play a critical role in To cite: Jing Y, Gimenes JA, exacerbation. Excessive production is a result of inducing GCH via activation of STAT6, SPDEF and Mishra R, et al. Thorax Epub 5–7 ahead of print: [please increased synthesis and secretion of mucins and is FOXA3. Therefore, most of the published studies include Day Month Year]. often associated with increase in number of goblet on allergic asthma have focused on delineating the doi:10.1136/ cells (goblet cell hyperplasia or GCH). Patients with molecular mechanisms by which respiratory viruses thoraxjnl-2017-210593 COPD show GCH in both small and large airways, induce IL-13.8–11 In COPD, however, viral infection Jing Y, et al. Thorax 2018;0:1–15. doi:10.1136/thoraxjnl-2017-210593 1 Chronic obstructive pulmonary disease is associated predominantly with CXCL-8, CXCL-10, TNF-α, Institutional Review Board, University of Michigan. Age and Thorax: first published as 10.1136/thoraxjnl-2017-210593 on 10 July 2018. Downloaded from IFN-γ and IL-6.12 Therefore, the role of IL-13 in virus-induced clinical status of COPD subjects and healthy donors are provided GCH in COPD is not clear. in online supplementary table 1. Airway basal cells at passage Another mechanism by which respiratory viruses may one were cultured at air/liquid interface as described previously induce GCH is via activation of epidermal growth factor to promote mucociliary differentiation.15 27 For details, please receptor (EGFR). Activation of EGFR has been shown to see the supplemental file. The sample size for COPD and normal induce GCH independently or in concert with IL-13. For cell cultures was determined based on our previous study,28 in instance, persistent activation of EGFR in mucociliary-differ- which we examined the goblet cell number. With the calculated entiated cell cultures by treatment with reactive oxygen species effect size of 2.87, α=0.05 and power of 0.95, we determined has been demonstrated to reduce number of ciliated cells and that we will require cells from six normal subjects and six subjects increase goblet cells.13 Chronic EGFR activation by Sendai virus with COPD. Therefore, we used cells from 8 to 9 patients in our induces GCH in well-differentiated airway epithelial cells by initial experiments to determine the difference in responses to promoting survival and transdifferentiation of ciliated to goblet RV between normal and COPD cell cultures. The sample size cells in concert with IL-13.14 Recently, we demonstrated that required for detecting significant differences between sham and RV promotes goblet cell differentiation in a model of injured RV infection in COPD cultures was determined based on the but not in normal airway epithelium via persistent activation of results of initial experiments (figure 2D), in which we quantified EGFR.15 Since EGFR activity is already enhanced in COPD,16 17 GCH induced by RV. With the effect size of 3.89, α=0.05 and RV may further activate EGFR to drive GCH independently or power of 0.95, we determined that we will require cells from in concert with IL-13. three normal subjects and three subjects with COPD. Therefore, In recent years, NOTCH signalling has emerged as one of the we used cells from 3– to 6 subjects to determine the mechanism key players in regulating goblet cell differentiation in conductive by which RV induces GCH in COPD cells. airways. NOTCH signalling pathway is evolutionarily conserved, and therefore all mammals express NOTCH receptors and Rhinovirus ligands. There are four NOTCH receptors (NOTCH1–4) and RV16 and RV1B purchased from ATCC were propagated in H1 five NOTCH ligands (delta-like ligand (DLL) 1, 2, 3, 4, and HeLa cells, partially purified, and viral titre was determined by jagged (JAG) 1 and 2). Human bronchial epithelial cells express plaque assay as described.29 Less than 100 kDa fraction from all four NOTCH receptors and all NOTCH ligands except for purified RV preparation was used as sham control. All in vitro DLL3.18 Overexpression of active domain of either NOTCH experiments were conducted with major group RV RV16 and in 1 or 3, but not 2 or 4, skewed differentiation of cells towards vivo studies with minor group virus RV1B, because major group secretory cells with a parallel decrease in ciliated cells. Similarly, viruses
Recommended publications
  • Epithelial IL-33 Appropriates Exosome Trafficking for Secretion in Chronic Airway Disease
    Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease Ella Katz-Kiriakos, … , Mark J. Miller, Jennifer Alexander-Brett JCI Insight. 2021;6(4):e136166. https://doi.org/10.1172/jci.insight.136166. Research Article Immunology Pulmonology Graphical abstract Find the latest version: https://jci.me/136166/pdf RESEARCH ARTICLE Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease Ella Katz-Kiriakos,1 Deborah F. Steinberg,1 Colin E. Kluender,1 Omar A. Osorio,1 Catie Newsom-Stewart,1 Arjun Baronia,1 Derek E. Byers,1 Michael J. Holtzman,1,2 Dawn Katafiasz,3 Kristina L. Bailey,3 Steven L. Brody,1 Mark J. Miller,4 and Jennifer Alexander-Brett1,5 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, and 2Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA. 3Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska Medical Center, Omaha, Nebraska, USA. 4Department of Medicine, Division of Infectious Diseases, and 5Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA. IL-33 is a key mediator of chronic airway disease driven by type 2 immune pathways, yet the nonclassical secretory mechanism for this cytokine remains undefined. We performed a comprehensive analysis in human airway epithelial cells, which revealed that tonic IL-33 secretion is dependent on the ceramide biosynthetic enzyme neutral sphingomyelinase 2 (nSMase2). IL-33 is cosecreted with exosomes by the nSMase2-regulated multivesicular endosome (MVE) pathway as surface-bound cargo. In support of these findings, human chronic obstructive pulmonary disease (COPD) specimens exhibited increased epithelial expression of the abundantly secreted IL33Δ34 isoform and augmented nSMase2 expression compared with non-COPD specimens.
    [Show full text]
  • University of Groningen Chronic Mucus Hypersecretion in COPD And
    University of Groningen Chronic mucus hypersecretion in COPD and asthma Tasena, Hataitip IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2019 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Tasena, H. (2019). Chronic mucus hypersecretion in COPD and asthma: Involvement of microRNAs and stromal cell-epithelium crosstalk. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 06-10-2021 Chronic mucus hypersecretion in COPD and asthma: Involvement of microRNAs and stromal cell-epithelium crosstalk Hataitip Tasena 531891-L-bw-Tasena Processed on: 6-6-2019 PDF page: 1 The studies presented in this thesis were performed within the framework of the Groningen University Institute for Drug Exploration (GUIDE), the Groningen Research Institute for Asthma and COPD (GRIAC), and U4 Ageing Lung Consortium.
    [Show full text]
  • A Cellular Census of Healthy Lung and Asthmatic Airway Wall
    bioRxiv preprint doi: https://doi.org/10.1101/527408; this version posted January 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 2 A cellular census of healthy lung and asthmatic airway wall identifies novel cell states 3 in health and disease 4 5 6 Vieira Braga, F.A.1,11*, Kar, G.1,11*, Berg, M.2,3,*, Carpaij, O.A.3,4,§, Polanski, K.1,§, Simon, 7 L.M.5, Brouwer, S.2,3 Gomes, T.1, Hesse, L.2,3, Jiang, J.2,3, Fasouli, E.S.1,11, Efremova, M.1, 8 Vento-Tormo, R.1, Affleck, K.7, Palit, S.5, Strzelecka, P.1,13,14, Firth, H.V.1, Mahbubani, 9 K.T.A.6, Cvejic, A.1,13,14, Meyer K.B.1, Saeb-Parsy, K.6, Luinge, M.2,3, Brandsma, C.-A.2,3, 10 Timens, W.2,3, Angelidis, I.9, Strunz, M.9, Koppelman, G.H.3,10, van Oosterhout, A.J.7, 11 Schiller, H.B.9, Theis, F.J.5,8, van den Berge, M.3,4, Nawijn, M.C.2,3,#,+ & Teichmann, 12 S.A.1,11,12,#,+ 13 14 1.Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, 15 United Kingdom. 16 2.University of Groningen, University Medical Center Groningen, Department of Pathology 17 & Medical Biology, Groningen, The Netherlands.
    [Show full text]
  • Airway Basal Cells Show a Dedifferentiated Krt17highphenotype and Promote Fibrosis in Idiopathic Pulmonary Fibrosis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.04.283408; this version posted September 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Airway Basal Cells show a dedifferentiated KRT17highPhenotype and promote Fibrosis in Idiopathic Pulmonary Fibrosis Benedikt Jaeger, Ph.D.1,2*, Jonas Christian Schupp, M.D.3*, Linda Plappert1,2, Oliver Terwolbeck1,2, Gian Kayser, M.D.4, Peggy Engelhard, Ph.D.5, Taylor Sterling Adams, B.S.3, Robert Zweigerdt, Ph.D.6, Henning Kempf, Ph.D.6, Stefan Lienenklaus, Ph.D.7, Wiebke Garrels, Ph.D.7, Irina Nazarenko, Ph.D.8,9, Danny Jonigk, M.D.2,10, Malgorzata Wygrecka, Ph.D11, Denise Klatt12, Axel Schambach, M.D. Ph.D.12,13, Naftali Kaminski, M.D.3#, Antje Prasse, M.D.1,2,14# 1 Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany 2 German Center for Lung Research, BREATH, Hannover, Germany 3 Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, USA 4 Institute of Surgical Pathology, University Medical Center, Freiburg, Germany 5 Department of Pneumology, University Medical Center Freiburg, Germany 6 Leibniz Research Laboratories for Biotechnology and Artificial Organs, Medical School Hannover, Germany 7 Institute for Laboratory Animal Science, Hannover Medical School, Hannover, Germany. 8 Institute for Infection Prevention and Hospital Epidemiology;
    [Show full text]
  • Small Airway-On-A-Chip Enables Analysis of Human Lung Inflammation and Drug Responses in Vitro
    Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Benam, Kambez H, Remi Villenave, Carolina Lucchesi, Antonio Varone, Cedric Hubeau, Hyun-Hee Lee, Stephen E Alves, et al. 2015. “Small Airway-on-a-Chip Enables Analysis of Human Lung Inflammation and Drug Responses in Vitro.” Nat Meth 13 (2) (December 21): 151–157. doi:10.1038/nmeth.3697. Published Version doi:10.1038/nmeth.3697 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:25623045 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA NATURE'MTHODS'-'in'press' Small airway-on-a-chip enables analysis of human lung inflammation and therapeutic responses in vitro Kambez H. Benam1,8, Remi Villenave1,8, Carolina Lucchesi1,7, Antonio Varone1,7, Cedric Hubeau2, Hyun-Hee Lee3, Stephen E. Alves3, Michael Salmon3, Thomas C. Ferrante1, James C. Weaver1,4, Geraldine A. Hamilton1,7, Anthony Bahinski1, and Donald E. Ingber1,4–6 1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA; 2Pfizer, Cambridge, Massachusetts, USA; 3Merck Research Laboratories, Boston, Massachusetts, USA; 4Harvard School of Engineering and Applied Sciences, Cambridge, Massachusetts, USA; 5Vascular Biology Program, Boston Children’s Hospital, Boston, Massachusetts, USA; 6Harvard Medical School, Boston, Massachusetts, USA; 7Current address: Emulate Inc., Cambridge, Massachusetts, USA; 8These authors contributed equally to this work.
    [Show full text]
  • POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes
    POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes This information is current as Haixia Zhou, Angelika Brekman, Wu-Lin Zuo, Xuemei Ou, of September 28, 2021. Renat Shaykhiev, Francisco J. Agosto-Perez, Rui Wang, Matthew S. Walters, Jacqueline Salit, Yael Strulovici-Barel, Michelle R. Staudt, Robert J. Kaner, Jason G. Mezey, Ronald G. Crystal and Guoqing Wang J Immunol 2016; 196:3159-3167; Prepublished online 29 Downloaded from February 2016; doi: 10.4049/jimmunol.1502400 http://www.jimmunol.org/content/196/7/3159 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2016/02/26/jimmunol.150240 Material 0.DCSupplemental References This article cites 43 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/196/7/3159.full#ref-list-1 Why The JI? Submit online. by guest on September 28, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • Cellular and Functional Heterogeneity of the Airway Epithelium
    www.nature.com/mi REVIEW ARTICLE Cellular and functional heterogeneity of the airway epithelium Jordan D. Davis1 and Tomasz P. Wypych 1 The airway epithelium protects us from environmental insults, which we encounter with every breath. Not only does it passively filter large particles, it also senses potential danger and alerts other cells, including immune and nervous cells. Together, these tissues orchestrate the most appropriate response, balancing the need to eliminate the danger with the risk of damage to the host. Each cell subset within the airway epithelium plays its part, and when impaired, may contribute to the development of respiratory disease. Here we highlight recent advances regarding the cellular and functional heterogeneity along the airway epithelium and discuss how we can use this knowledge to design more effective, targeted therapeutics. Mucosal Immunology (2021) 14:978–990; https://doi.org/10.1038/s41385-020-00370-7 INTRODUCTION subset plays in health and disease, and explore the immunological Respiration, be it through lungs, gills or skin, is a defining feature of contributions of airway epithelium. life. In humans, the respiratory system is often divided into the proximal conducting airways, including the nasal cavity, trachea 1234567890();,: and bronchi, and the distal respiratory airways, including the THE OLD AND THE NEW: CELLS OF THE AIRWAY EPITHELIUM respiratory bronchioles and alveoli.1 Though the primary respon- AND THEIR CONTRIBUTIONS TO HEALTH AND DISEASE sibility of the respiratory system is to carry out efficient gas Basal cells exchange between inhaled air and the bloodstream, it also plays a Basal cells are cuboidal in shape, secured to the basement pivotal role in maintaining respiratory homeostasis, and when membrane,11 and identifiable through expression of cytokeratins dysregulated, can contribute to disease (Fig.
    [Show full text]
  • Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections
    biology Review Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections Adivitiya 1, Manish Singh Kaushik 1 , Soura Chakraborty 1, Shobi Veleri 2 and Suneel Kateriya 1,* 1 Laboratory of Optobiology, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India; [email protected] (A.); [email protected] (M.S.K.); [email protected] (S.C.) 2 Drug Safety Division, ICMR-National Institute of Nutrition, Hyderabad 500007, India; [email protected] * Correspondence: [email protected] Simple Summary: Mucociliary clearance constitutes an innate lung defense mechanism that is primarily driven by ciliated cells. Respiratory mucus traps pathogens entering the airways, and lung cilia propel them outward via their coordinated directional motion. Thus, damage to the component(s) of this apparatus will hamper its smooth functioning. Here, we update the cellular and molecular machinery that constitutes and regulates mucociliary clearance (MCC). We also describe several respiratory diseases arising due to genetic or acquired molecular shortcomings in the MCC. The past few decades have seen the emergence of novel viruses that inflame and damage the respiratory tract. Coronaviruses have been observed to disrupt the ciliated epithelium and abolish its integrity. Bearing in mind the havoc created by the ongoing pandemic, we outline the significance of the ciliated respiratory epithelium in defense against such microbial infections. We have predicted protein interaction networks depicting severe acute respiratory syndrome coronavirus-2 (SARS-CoV- 2)-manifested implications on the molecular machinery regulating mucociliary clearance. Several proteins involved in the network were found to interact with SARS-CoV-2 viral proteins upon host Citation: Adivitiya; Kaushik, M.S.; infection.
    [Show full text]
  • Long-Term IL-33–Producing Epithelial Progenitor Cells in Chronic Obstructive Lung Disease
    Amendment history: Corrigendum (December 2013) Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease Derek E. Byers, … , Steven L. Brody, Michael J. Holtzman J Clin Invest. 2013;123(9):3967-3982. https://doi.org/10.1172/JCI65570. Research Article Chronic obstructive lung disease is characterized by persistent abnormalities in epithelial and immune cell function that are driven, at least in part, by infection. Analysis of parainfluenza virus infection in mice revealed an unexpected role for innate immune cells in IL-13–dependent chronic lung disease, but the upstream driver for the immune axis in this model and in humans with similar disease was undefined. We demonstrate here that lung levels of IL-33 are selectively increased in postviral mice with chronic obstructive lung disease and in humans with very severe chronic obstructive pulmonary disease (COPD). In the mouse model, IL-33/IL-33 receptor signaling was required for Il13 and mucin gene expression, and Il33 gene expression was localized to a virus-induced subset of airway serous cells and a constitutive subset of alveolar type 2 cells that are both linked conventionally to progenitor function. In humans with COPD, IL33 gene expression was also associated with IL13 and mucin gene expression, and IL33 induction was traceable to a subset of airway basal cells with increased capacities for pluripotency and ATP-regulated release of IL-33. Together, these findings provide a paradigm for the role of the innate immune […] Find the latest version: https://jci.me/65570/pdf Research article Long-term IL-33–producing epithelial progenitor cells in chronic obstructive lung disease Derek E.
    [Show full text]
  • The Antimicrobial Protein Rnase 7 of the Airway Epithelium Through
    Basal Cells Contribute to Innate Immunity of the Airway Epithelium through Production of the Antimicrobial Protein RNase 7 This information is current as Gimano D. Amatngalim, Yolanda van Wijck, Yvonne de of September 23, 2021. Mooij-Eijk, Renate M. Verhoosel, Jürgen Harder, Annemarie N. Lekkerkerker, Richard A. J. Janssen and Pieter S. Hiemstra J Immunol 2015; 194:3340-3350; Prepublished online 23 February 2015; Downloaded from doi: 10.4049/jimmunol.1402169 http://www.jimmunol.org/content/194/7/3340 Supplementary http://www.jimmunol.org/content/suppl/2015/02/21/jimmunol.140216 http://www.jimmunol.org/ Material 9.DCSupplemental References This article cites 47 articles, 12 of which you can access for free at: http://www.jimmunol.org/content/194/7/3340.full#ref-list-1 Why The JI? Submit online. by guest on September 23, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Basal Cells Contribute to Innate Immunity of the Airway Epithelium through Production of the Antimicrobial Protein RNase 7 Gimano D.
    [Show full text]
  • Microarray Analysis Identifies Defects in Regenerative and Immune Response Pathways in COPD Airway Basal Cells
    ORIGINAL ARTICLE COPD Microarray analysis identifies defects in regenerative and immune response pathways in COPD airway basal cells Fanny Pineau1, Gabriella Shumyatsky1, Nicole Owuor1, Nisha Nalamala1, Sudhir Kotnala1, Sudhir Bolla1, Nathaniel Marchetti1, Steven Kelsen1, Gerard J. Criner1 and Uma S. Sajjan 1,2 Affiliations: 1Dept of Thoracic Surgery and Medicine, Temple University, Philadelphia, PA, USA. 2Dept of Physiology, Lewis Katz Medical School, Temple University, Philadelphia, PA, USA. Correspondence: Uma S. Sajjan, Temple University, 3500 N. Broad Street, Philadelphia, PA 19140, USA. E-mail: [email protected] ABSTRACT Background: Airway basal cells are specialised stem cells and regenerate airway epithelium. Airway basal cells isolated from patients with COPD regenerate airway epithelium with an abnormal phenotype. We performed gene expression analysis to gain insights into the defective regenerative programme in COPD basal cells. Methods: We conducted microarray analysis and compared COPD versus normal basal cells to identify differentially regulated genes (DEGs) and the enriched biological pathways. We determined the correlation of DEGs with cell polarisation and markers of ciliated and goblet cells. HOXB2 was knocked down in 16HBE14o− cells and monitored for polarisation of cells. HOXB2 expression in the lung sections was determined by immunofluorescence. Results: Comparison of normal and COPD basal cell transcriptomic profiles highlighted downregulation of genes associated with tissue development, epithelial cell differentiation and antimicrobial humoral response. Expression of one of the tissue development genes, HOXB2 showed strong correlation with transepithelial resistance and this gene was downregulated in COPD basal cells. Knockdown of HOXB2, abrogated polarisation of epithelial cells in normal cells. Finally, HOXB2 expression was substantially reduced in the bronchial epithelium of COPD patients.
    [Show full text]
  • Notch Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling
    1521-0111/92/6/676–693$25.00 https://doi.org/10.1124/mol.117.110254 MOLECULAR PHARMACOLOGY Mol Pharmacol 92:676–693, December 2017 Copyright ª 2017 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW Notch Signaling: Linking Embryonic Lung Development and Asthmatic Airway Remodeling Musaddique Hussain, Chengyun Xu, Mashaal Ahmad, Youping Yang, Meiping Lu, Xiling Wu, Lanfang Tang, and Ximei Wu Downloaded from Department of Pharmacology and The Key Respiratory Drug Research Laboratory of China Food and Drug Administration, School of Medicine, Zhejiang University, Hangzhou City, China (M.H., C.X., M.A., Xim.W.); The Second People’s Hospital of Wenling, Wenling City, Zhejiang Province, China (Y.Y.); and Department of Respiratory Medicine, the Affiliated Children Hospital, School of Medicine, Zhejiang University, Hangzhou City, China (M.L., Xil.W., L.T.) Received August 14, 2017; accepted October 11, 2017 molpharm.aspetjournals.org ABSTRACT Lung development is mediated by assorted signaling proteins and imperative for appropriate lung development. Moreover, evidence orchestrated by complex mesenchymal-epithelial interactions. suggests that Notch signaling links embryonic lung development Notch signaling is an evolutionarily conserved cell-cell communi- and asthmatic airway remodeling. Herein, we summarized all- cation mechanism that exhibits a pivotal role in lung development. recent advances associated with the mechanistic role of Notch Notably, both aberrant expression and loss of regulation of Notch signalinginlungdevelopment,consequences
    [Show full text]